Pharmaceutical

Doctors call out ableism in cancer care: ‘The biggest a...

Doctors' assumptions about patients with disabilities can undermine cancer care ...

STAT+: Could sickle cell someday be treated not with CR...

Novartis unveiled early animal data suggesting that they might have a promising ...

STAT+: Humana used algorithm in ‘fraudulent scheme’ to ...

Medicare Advantage beneficiaries on Tuesday filed a class-action lawsuit allegin...

STAT+: Maze CEO ‘personally disappointed’ in Sanofi dec...

The CEO of Maze Therapeutics said he learned Sanofi would end its partnership wi...

STAT+: A targeted therapy shows it can offer a ‘last, g...

A new type of targeted therapy enabled a leukemia patient to "see my dog, hang o...

STAT+: Bone marrow transplant advance could widen use o...

Researchers reported advances in bone marrow transplants, a less expensive way t...

STAT+: Bankrupt Pear’s addiction treatments acquired by...

Half a year after selling its assets at bankruptcy auction, Pear Therapeutics’ m...

STAT+: New federal rules demand transparency into AI mo...

New federal rules will force software vendors to disclose how AI tools used in h...

Opinion: Exceptions to abortion restrictions often fail...

Exceptions to abortion restrictions often fail people like Kate Cox whose babies...

STAT+: After decade-long dispute over CRISPR-Cas9, Edit...

For a decade, leading academic institutes and their associated companies fought ...

Supreme Court will decide abortion pill access

The Supreme Court agreed Wednesday to take on whether Americans can access a com...

Morning Rounds: For kids with high BMI, task force not ...

Understand how science, health policy, and medicine shape the world everyday. Si...

A plot to solve the ‘whack-a-mole’ of drug discovery

Want to stay on top of the science and politics driving biotech today? Sign up t...

STAT+: Pharmalittle: Employers hire virtual providers a...

U.S. employers facing surging costs from obesity drugs are hiring virtual provid...

STAT+: Pfizer says 2024 profits will fall far below exp...

Pfizer said Wednesday that its 2024 profits would fall far below investor expect...

STAT+: Vertex non-opioid drug reduces chronic nerve pai...

Vertex Pharmaceuticals said an experimental drug reduced pain in people with dia...